These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31968132)

  • 1. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.
    Loid P; Hauta-Alus H; Mäkitie O; Magnusson P; Mäkitie RE
    Front Endocrinol (Lausanne); 2022; 13():954730. PubMed ID: 36157448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
    Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
    J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations.
    Fratzl-Zelman N; Wesseling-Perry K; Mäkitie RE; Blouin S; Hartmann MA; Zwerina J; Välimäki VV; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    Bone; 2021 May; 146():115900. PubMed ID: 33618074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
    Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
    J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling.
    Mäkitie RE; Hackl M; Niinimäki R; Kakko S; Grillari J; Mäkitie O
    J Clin Endocrinol Metab; 2018 May; 103(5):1985-1996. PubMed ID: 29506076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.
    Costantini A; Mäkitie RE; Hartmann MA; Fratzl-Zelman N; Zillikens MC; Kornak U; Søe K; Mäkitie O
    J Bone Miner Res; 2022 Sep; 37(9):1623-1641. PubMed ID: 35949115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
    Verdonk SJE; Storoni S; Zhytnik L; Zhong W; Pals G; van Royen BJ; Elting MW; Maugeri A; Eekhoff EMW; Micha D
    Calcif Tissue Int; 2023 Aug; 113(2):186-194. PubMed ID: 37277619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/β-catenin pathway inhibitors, bone metabolism and vascular health in kidney transplant patients.
    Wang YP; Sidibé A; Fortier C; Desjardins MP; Ung RV; Kremer R; Agharazii M; Mac-Way F
    J Nephrol; 2023 May; 36(4):969-978. PubMed ID: 36715822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults.
    Mäkitie RE; Haanpää M; Valta H; Pekkinen M; Laine CM; Lehesjoki AE; Schalin-Jäntti C; Mäkitie O
    J Bone Miner Res; 2016 Sep; 31(9):1734-42. PubMed ID: 27005318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
    Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
    Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Genetic Forms of Childhood-Onset Primary Osteoporosis.
    Kämpe AJ; Mäkitie RE; Mäkitie O
    Horm Res Paediatr; 2015; 84(6):361-9. PubMed ID: 26517534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Mäkitie RE; Niinimäki R; Kakko S; Honkanen T; Kovanen PE; Mäkitie O
    Osteoporos Int; 2018 Feb; 29(2):479-487. PubMed ID: 29147753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired bone strength and bone microstructure in a novel early-onset osteoporotic rat model with a clinically relevant
    Hu J; Zhou B; Lin X; Zhang Q; Guan F; Sun L; Liu J; Wang O; Jiang Y; Xia WB; Xing X; Li M
    Elife; 2023 Apr; 12():. PubMed ID: 37083757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis.
    Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z
    Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Osteoporos Int; 2017 Mar; 28(3):945-953. PubMed ID: 27766367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.